Niacin for primary and secondary prevention of cardiovascular events-Reference-Cited by-同舟云学术

Niacin for primary and secondary prevention of cardiovascular events

Published:2012-03-14 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Saccilotto Ramon,Kasenda Benjamin,Nordmann Alain J,Briel Matthias

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009744/epdf/full

Reference50 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. AIM HIGH: Niacin Plus Statin To Prevent Vascular Events Available from: http://clinicaltrials.gov/ct2/show/NCT00120289

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90â€ˆ056 participants in 14 randomised trials of statins;Baigent;The Lancet,2005

4. Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study;Ballantyne Christie;Journal of clinical lipidology,2008

5. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study);Ballantyne Christie;The American journal of cardiology,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

;Vascular Health and Risk Management;2020-10